City of Hope Medical Center: Prostatic Neoplasms trials

The registry lists 35 Prostatic Neoplasms studies with City of Hope Medical Center as lead sponsor. 12 are open to participants now and 7 have results posted.

Phase 1 8Phase 2 10Phase 3 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate CancerRecruitingNCT07790718Not applicable
• Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate CancerNot yet recruitingNCT07769372Not applicable
• 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate CancerRecruitingNCT07219147Phase 1
• Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)RecruitingNCT07210086Phase 2
• Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT TrialRecruitingNCT07202247Phase 2
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination TherapyRecruitingNCT05869682Phase 2
• PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate CancerRecruitingNCT05805371Phase 1
• A Study on the Effects of Exercise Therapy on Signs of Prostate CancerRecruitingNCT05751434Phase 2
• Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruitingNCT05519878Not applicable
• Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate CancerRecruitingNCT04775355
• Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerRecruitingNCT04734730Phase 2
• Researching the Effect of Exercise on CancerRecruitingNCT04589468Not applicable
• RefleXion PET/CT Imaging Performance in Patients With Prostate CancerActive, not recruitingNCT05470699Not applicableResults posted
• HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of GenomicsActive, not recruitingNCT04905082Not applicableResults posted
• PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT03873805Phase 1Results posted
• Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate CancerCompletedNCT01967862Not applicableResults posted
• Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate CancerCompletedNCT01807065Phase 2Results posted
• Axitinib Before Surgery in Treating Patients With High-Risk Prostate CancerCompletedNCT01385059Phase 2Results posted
• ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate CancerTerminatedNCT00544076Phase 3Results posted
• Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane ChemotherapyCompletedNCT07218718Not applicable
• [18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate CancerActive, not recruitingNCT06580015Not applicable
• Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersActive, not recruitingNCT05722288Phase 2
• White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CASuspendedNCT04519879Phase 2
• Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesCompletedNCT04501913
• Long-Term Follow-Up in Patients With Prostate Cancer After SurgeryCompletedNCT03035500Not applicable
• Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage II Prostate Cancer Undergoing SurgeryCompletedNCT02119858Phase 1
• Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate CancerCompletedNCT02048150Phase 1
• Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing SurgeryActive, not recruitingNCT01923506Phase 1
• Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate CancerCompletedNCT01613651Phase 3
• Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy OutcomeActive, not recruitingNCT01441687Not applicable
• Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerCompletedNCT01277562
• Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryActive, not recruitingNCT00977457Phase 1
• Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung CancerCompletedNCT00900835Not applicable
• White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local TherapyCompletedNCT00779168Phase 1
• Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone TherapyCompletedNCT00005857Phase 2